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Condoms and STDs:
Fact Sheet for Public Health Personnel
Consistent and correct use of male latex condoms can reduce (though not eliminate) the risk of STD 
transmission. To achieve the maximum protective effect, condoms must be used both consistently and correctly. 
Inconsistent use can lead to STD acquisition because transmission can occur with a single act of intercourse with 
an infected partner. Similarly, if condoms are not used correctly, the protective effect may be diminished even 
when they are used consistently. The most reliable ways to avoid transmission of sexually transmitted diseases 
(STDs), including human immunodeficiency virus (HIV), are to abstain from sexual activity or to be in a long-
term mutually monogamous relationship with an uninfected partner. However, many infected persons may be 
unaware of their infections because STDs are often asymptomatic or unrecognized.
This fact sheet presents evidence concerning the male latex condom and the prevention of STDs, including HIV, based 
on information about how different STDs are transmitted, the physical properties of condoms, the anatomic coverage or 
protection that condoms provide, and epidemiologic studies assessing condom use and STD risk. This fact sheet updates 
previous CDC fact sheets on male condom effectiveness for STD prevention by incorporating additional evidence-based 
findings from published epidemiologic studies.
Sexually Transmitted Diseases, Including HIV Infection
Latex condoms, when used consistently and correctly, are highly effective in 
preventing the sexual transmission of HIV, the virus that causes AIDS. In ad-
dition, consistent and correct use of latex condoms reduces the risk of other 
sexually transmitted diseases (STDs), including diseases transmitted by genital 
secretions, and to a lesser degree, genital ulcer diseases. Condom use may reduce 
the risk for genital human papillomavirus (HPV) infection and HPV-associated 
diseases, e.g., genital warts and cervical cancer. 
There are two primary ways that STDs are transmitted. Some diseases, such as HIV 
infection, gonorrhea, chlamydia, and trichomoniasis, are transmitted when infected urethral 
or vaginal secretions contact mucosal surfaces (such as the male urethra, the vagina, or 
cervix). In contrast, genital ulcer diseases (such as genital herpes, syphilis, and chancroid) 
and human papillomavirus (HPV) infection are primarily transmitted through contact with 
infected skin or mucosal surfaces.
Laboratory studies have demonstrated that latex condoms provide an essentially 
impermeable barrier to particles the size of STD pathogens.
Theoretical and empirical basis for protection. Condoms can be expected to provide 
different levels of protection for various STDs, depending on differences in how the diseases 
are transmitted. Condoms block transmission and acquisition of STDs by preventing 
contact between the condom wearer’s penis and a sex partner’s skin, mucosa, and genital 
secretions.  A greater level of protection is provided for the diseases transmitted by genital 
secretions.  A lesser degree of protection is provided for genital ulcer diseases or HPV 
because these infections also may be transmitted by exposure to areas (e.g., infected skin or 
mucosal surfaces) that are not covered or protected by the condom.
Epidemiologic studies seek to measure the protective effect of condoms by comparing 
risk of STD transmission among condom users with nonusers who are engaging in sexual 
intercourse.  Accurately estimating the effectiveness of condoms for prevention of STDs, 
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however, is methodologically challenging. Well-designed 
studies address key factors such as the extent to which 
condom use has been consistent and correct and whether 
infection identified is incident (i.e., new) or prevalent (i.e. 
pre-existing). Of particular importance, the study design 
should assure that the population being evaluated has 
documented exposure to the STD of interest during the 
period that condom use is being assessed. Although consistent 
and correct use of condoms is inherently difficult to measure, 
because such studies would involve observations of private 
behaviors, several published studies have demonstrated that 
failure to measure these factors properly tends to result in 
underestimation of condom effectiveness.
Epidemiologic studies provide useful information regarding 
the magnitude of STD risk reduction associated with condom 
use.  Extensive literature review confirms that the best 
epidemiologic studies of condom effectiveness address HIV 
infection.  Numerous studies of discordant couples (where 
only one partner is infected) have shown consistent use of 
latex condoms to be highly effective for preventing sexually 
acquired HIV infection. Similarly, studies have shown that 
condom use reduces the risk of other STDs. However, the 
overall strength of the evidence regarding the effectiveness of 
condoms in reducing the risk of other STDs is not at the level 
of that for HIV, primarily because fewer methodologically 
sound and well-designed studies have been completed that 
address other STDs. Critical reviews of all studies, with both 
positive and negative findings (referenced here) point to the 
limitations in study design in some studies which result in 
underestimation of condom effectiveness; therefore, the true 
protective effect is likely to be greater than the effect observed. 
Overall, the preponderance of available epidemiologic 
studies have found that when used consistently and correctly, 
condoms are highly effective in preventing the sexual 
transmission of HIV infection and reduce the risk of other 
STDs. 
The following includes specific information for HIV 
infection, diseases transmitted by genital secretions, genital 
ulcer diseases, and HPV infection, including information on 
laboratory studies, the theoretical basis for protection and 
epidemiologic studies.
HIV, the virus that causes AIDS
Latex condoms, when used consistently and correctly, are highly effective 
in preventing the sexual transmission of HIV, the virus that causes AIDS
HIV infection is, by far, the most deadly STD, and considerably more scientific 
evidence exists regarding condom effectiveness for prevention of HIV infection 
than for other STDs. The body of research on the effectiveness of latex condoms 
in preventing sexual transmission of HIV is both comprehensive and conclusive. 
The ability of latex condoms to prevent transmission of HIV has been scientifically 
established in “real-life” studies of sexually active couples as well as in laboratory 
studies.
Laboratory studies have demonstrated that latex condoms provide an essentially 
impermeable barrier to particles the size of HIV.
Theoretical basis for protection. Latex condoms cover the penis and provide an 
effective barrier to exposure to secretions such as urethral and vaginal secretions, 
blocking the pathway of sexual transmission of HIV infection.
Epidemiologic studies that are conducted in real-life settings, where one partner is 
infected with HIV and the other partner is not, demonstrate that the consistent use 
of latex condoms provides a high degree of protection. 
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Other Diseases transmitted by genital secretions, 
including Gonorrhea, Chlamydia, and Trichomoniasis
Latex condoms, when used consistently and correctly, reduce the 
risk of transmission of STDs such as gonorrhea, chlamydia, and 
trichomoniasis. 
STDs such as gonorrhea, chlamydia, and trichomoniasis are sexually transmitted 
by genital secretions, such as urethral or vaginal secretions.
Laboratory studies have demonstrated that latex condoms provide an essentially 
impermeable barrier to particles the size of STD pathogens. 
Theoretical basis for protection. The physical properties of latex condoms protect 
against diseases such as gonorrhea, chlamydia, and trichomoniasis by providing a 
barrier to the genital secretions that transmit STD-causing organisms. 
Epidemiologic studies that compare infection rates among condom users and 
nonusers provide evidence that latex condoms can protect against the transmission 
of STDs such as chlamydia, gonorrhea and trichomoniasis.
Genital ulcer diseases and HPV infections
Genital ulcer diseases and HPV infections can occur in both male and female genital areas that are covered or 
protected by a latex condom, as well as in areas that are not covered. Consistent and correct use of latex con-
doms reduces the risk of genital herpes, syphilis, and chancroid only when the infected area or site of potential 
exposure is protected. Condom use may reduce the risk for HPV infection and HPV-associated diseases (e.g., 
genital warts and cervical cancer).
Genital ulcer diseases include genital herpes, syphilis, and 
chancroid. These diseases are transmitted primarily through 
“skin-to-skin” contact from sores/ulcers or infected skin 
that looks normal. HPV infections are transmitted through 
contact with infected genital skin or mucosal surfaces/secre-
tions. Genital ulcer diseases and HPV infection can occur in 
male or female genital areas that are covered (protected by the 
condom) as well as those areas that are not.
Laboratory studies have demonstrated that latex condoms 
provide an essentially impermeable barrier to particles the size 
of STD pathogens. 
Theoretical basis for protection. Protection against genital 
ulcer diseases and HPV depends on the site of the sore/ulcer 
or infection. Latex condoms can only protect against trans-
mission when the ulcers or infections are in genital areas that 
are covered or protected by the condom. Thus, consistent and 
correct use of latex condoms would be expected to protect 
against transmission of genital ulcer diseases and HPV in 
some, but not all, instances. 
Epidemiologic studies that compare infection rates 
among condom users and nonusers provide evidence that 
latex condoms provide limited protection against syphilis 
and herpes simplex virus-2 transmission. No conclusive 
studies have specifically addressed the transmission of 
chancroid and condom use, although several studies have 
documented a reduced risk of genital ulcers associated 
with increased condom use in settings where chancroid is 
a leading cause of genital ulcers. 
Condom use may reduce the risk for HPV-associated 
diseases (e.g., genital warts and cervical cancer) and may 
mitigate the other adverse consequences of infection with 
HPV; condom use has been associated with higher rates of 
regression of cervical intraepithelial neoplasia (CIN) and 
clearance of HPV infection in women, and with regression 
of HPV-associated penile lesions in men. A limited num-
ber of prospective studies have demonstrated a protective 
effect of condoms on the acquisition of genital HPV. 
While condom use has been associated with a lower risk 
of cervical cancer, the use of condoms should not be a 
substitute for routine screening with Pap smears to detect 
and prevent cervical cancer, nor should it be a substitute 
for HPV vaccination among those eligible for the vaccine
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